ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription

ARID1A loss in adult hepatocytes activates β-catenin-mediated erythropoietin transcription

Erythropoietin (EPO) is a key regulator of erythropoiesis. The embryonic liver is the main site of erythropoietin synthesis, after which the kidney takes over. The adult liver retains the ability to express EPO, and we discovered here new players of this transcription, distinct from the classical hy...

Full description

Bibliographic Details
Main Authors:	Rozenn Riou, Meriem Ladli, Sabine Gerbal-Chaloin, Pascale Bossard, Angélique Gougelet, Cécile Godard, Robin Loesch, Isabelle Lagoutte, Franck Lager, Julien Calderaro, Alexandre Dos Santos, Zhong Wang, Frédérique Verdier, Sabine Colnot
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2020-10-01
Series:	eLife
Subjects:	chromatin remodeling Wnt signaling epo transcription liver physiopathology
Online Access:	https://elifesciences.org/articles/53550

Similar Items

A Complex Interplay between Wnt/β-Catenin Signalling and the Cell Cycle in the Adult Liver
by: Angélique Gougelet, et al.
Published: (2012-01-01)

Inhibition der Müllerzellschwellung durch Erythropoietin unter hypotonen Bedingungen
by: Sauer, Katja
Published: (2013)

Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity
by: Amalia Merelli, et al.
Published: (2019-07-01)

The role of recombinant Human erythropoietin in neonatal anemia
by: Dalia M. El-Lahony, et al.
Published: (2020-09-01)

Erythropoietin non-viral gene therapy does not affect motility, viability, morphology or concentration of rabbit sperm
by: T.F. Collares, et al.
Published: (2013-01-01)

Detection of antibodies to erythropoietin-based drugs: is it possible to create the universal test system?
by: A. M. Kudryashova, et al.
Published: (2021-06-01)

Comparison of Immobilized Metal Affinity Chromatography Ni-NTA and Co-TALON for the Purification of Recombinant Human Erythropoietin
by: Yana Rubiyana, et al.
Published: (2015-12-01)

Stability of erythropoietin repackaging in polypropylene syringes for clinical use
by: Angela Marsili, et al.
Published: (2017-02-01)

Erythropoietin and the use of a transgenic model of erythropoietin-deficient mice
by: Pichon A, et al.
Published: (2016-04-01)

The efficacy of darbepoetin alpha in hemodialysis patients resistant to human recombinant erythropoietin (rHuEpo)
by: Hejaili Fayez
Published: (2009-01-01)

Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
by: Anna Thawanny Gadelha Moura, et al.

Erythropoietin treatment enhances mitochondrial function in human skeletal muscle
by: Ulla ePlenge, et al.
Published: (2012-03-01)

Impact of Erythropoietin Production by Erythroblastic Island Macrophages on Homeostatic Murine Erythropoiesis
by: Genève Perron-Deshaies, et al.
Published: (2020-11-01)

Evaluation of erythropoietin therapy in hemodialysis patients at PKU Muhammadiyah Hospital Yogyakarta
by: Adnan Adnan, et al.
Published: (2018-11-01)

PRECLINICAL STUDIES ON PLEIOTROPIC FUNCTIONS OF ERYTHROPOIETIN ON BONE HEALING
by: R. Vasileva, et al.
Published: (2021-03-01)

ΗΙF1α, EGR1 and SP1 co-regulate the erythropoietin receptor expression under hypoxia: an essential role in the growth of non-small cell lung cancer cells
by: Tianhong Su, et al.
Published: (2019-11-01)

The effects of topical erythropoietin on non-surgical treatment of periodontitis: a preliminary study
by: Hoori Aslroosta, et al.
Published: (2021-05-01)

Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
by: Yasunori Iwata, et al.
Published: (2021-05-01)

Prognostic factors in renal cell carcinoma : evaluation of erythropoietin and its receptor, carbonic anhydrase IX, parathyroid hormone-related protein and osteopontin
by: Papworth, Karin
Published: (2011)

Renal erythropoietin-producing cells in health and disease
by: Tomokazu eSouma, et al.
Published: (2015-06-01)

Acquired pure red cell aplasia following recombinant erythropoietin (darbepoetin-alfa) therapy
by: Somanath Padhi, et al.
Published: (2020-01-01)

Ein mathematisches Kompartimentmodell der murinen Erythro- und Granulopoese unter simultaner Gabe von Erythropoietin und G-CSF
by: Gebauer, Corinna Mirjam
Published: (2011)

Successful treatment of severe anemia using erythropoietin in a Jehovah Witness with non-Hodgkin lymphoma
by: Alexandra Agapidou, et al.
Published: (2014-12-01)

Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia
by: Feng Zhang, et al.
Published: (2007-01-01)

Impact of Erythropoietin in the management of Hypoxic Ischaemic Encephalopathy in resource-constrained settings: protocol for a randomized control trial
by: Beatrice Ezenwa, et al.
Published: (2020-05-01)

The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?
by: Séverine eLamon, et al.
Published: (2013-07-01)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
by: M. Moransard, et al.
Published: (2017-10-01)

Mathematical model for the application of Metabolic Flux Analysis to CHO cells producing recombinant human erythropoietin
by: Osmán Fernández, et al.

Synthesis and biological evaluation of 125I-erythropoietin as a potential radiopharmaceutical agent for tumours
by: Gonçalo dos Santos Clemente, et al.
Published: (2011-03-01)

Effects of erythropoietin combined with tissue plasminogen activator on the rats following cerebral ischemia and reperfusion
by: Rongliang Wang, et al.
Published: (2016-01-01)

Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia
by: Rhonda Souvenir, et al.
Published: (2011-10-01)

Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
by: Megan L. Noonan, et al.
Published: (2020-06-01)

Calcium homeostasis in red blood cells of dialysis patients   in dependence of erythropoietin treatment
by: Jue eWang, et al.
Published: (2014-01-01)

Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor
by: Hellewell, Sarah, et al.
Published: (2013)

PURIFICATION AND ANALYSIS OF CARBOHYDRATE CLUSTER FROM ERYTHROPOIETIN RECOMBINANT EXPRESSION RESULT ON THE LEAVEN SYSTEM OF Pichia pastoris
by: Adi Santoso, et al.
Published: (2011-04-01)

Comparison between two treatment protocols with recombinant Human Erythropoietin (rHuEpo) in the treatment of late anemia in neonates with Rh-Isoimmunization
by: A.A. Zuppa, et al.
Published: (2012-08-01)

Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues
by: Martin Begemann, et al.
Published: (2021-09-01)

A Single 60.000 IU Dose of Erythropoietin Does Not Improve Short-Term Aerobic Exercise Performance in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial
by: Thomas Haider, et al.
Published: (2020-09-01)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
by: Federica Rey, et al.
Published: (2021-01-01)

Erythropoetin and erythropoetin receptor systems, and oxidative status in patients with basal cell
by: Ergul Belge Kurutas, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_p494kfmoa91le3msvio4iu92qm